课题基金基金详情
EGFRvⅢ/Akt/PKcs通路在低剂量超微分割照射克服胶质瘤干细胞放疗抵抗的作用及机制
结题报告
批准号:
81372408
项目类别:
面上项目
资助金额:
62.0 万元
负责人:
李光辉
学科分类:
H1821.肿瘤治疗抵抗
结题年份:
2017
批准年份:
2013
项目状态:
已结题
项目参与者:
龙海霞、张岸梅、王欣欣、陈媛媛、马传坤
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
胶质瘤干细胞(GSCs)放疗抵抗是胶质瘤复发和治疗失败的重要原因。基于肿瘤细胞低剂量放疗超敏现象,我们建立新的放疗方法、低剂量超微分割放疗(ld-UmRT),即采用0.2Gy超微分割,每个超微分割间隔3分钟。前期研究结果显示ld-UmRT显著增强对GSCs杀伤作用。基于EGFR-Akt-PKcs信号通路在DNA双链断裂修复、细胞存活中的关键作用,结合我们前期发现GSCs表达EGFRvⅢ和ld-UmRT后GSCs内PKcs活化受抑的证据,推测EGFRvⅢ-Akt-PKcs途径在ld-UmRT克服GSCs放疗抵抗中起重要作用。拟通过体内外实验观察:GSCs在ld-UmRT后EGFRvⅢ-Akt-PKcs信号通路表达、活化;干预该信号通路后对GSCs在ld-UmRT及常规放疗后损伤效应变化。通过本研究,不但有利于完善GSCs放疗抵抗的分子机制,也将为ldUmRT特异性杀伤GSCs应用提供理论依据
英文摘要
Radiotherapy is the most effective nonsurgical treatment modality yet recurrence is essentially universal. Glioblastoma stem cells (GSCs), which was able to initiate or reconstitue tumor, is highly resistant to irradiation. The survival of GSCs play an important role on recurrence of glioma. The phenomena of low-dose hyper-radiosensitivity were seen in several tumor cells. A low-dose-rate ultra-microfraction (ld-UmRT) of radiotherapy was used to treat the GSCs by us. The daily fractions of 2 Gy were divided to 10 ultra-microfractions and every 0.2 Gy ultra-microfraction separated by 3 min time intervals. Then, the dose rate of 4~6 Gy/min was created to a low-dose-rate of 0.07 Gy/min. The survival rate decreased significant in GSCs after ld-UmRT compared to conventional radiotherapy in vitro. The most lethal among radiation-induced DNA lesions is the double-strand break (DSB). DSB repair is critical for cell survival after radiation induced DSB. There are data suggesting that EGFR-Akt-PKcs signaling pathways played an important role in radiosensitivity of tumor cell such as glioma cell and so on. We found that EGFRvⅢ was expressed in GSCs and the active of PKcs was inhibited in GSCs after GSCs received ld-UmRT. Therefore, We hypothesis that the DSB repair of GSCs depended on EGFRvⅢ/Akt/PKcs signaling pathways and this pathways was inhibited by ld-UmRT in GSCs. The EGFRvⅢ/Akt/PKcs signaling pathways will be tested in GSCs after ld-UmRT and the effect of ld-UmRT or conventional radiotherapy on blockage of EGFRvⅢ/Akt/PKcs signaling pathways in GSCs will be observed in our future work. The results of this study will help us to understand the mechanism of ld-UmRT increasing damage in GSCs.
EGFR高表达于约40%的人脑胶质母细胞瘤(Glioblastoma,GBM),其缺失外显子2-7的胞外段变异体EGFRvIII表达于20~30%的GBM患者。EGFRvIII具有不依赖配体结合即自身活化的重要特征,GBM细胞EGFRvIII表达是肿瘤细胞增殖、治疗抵抗的重要因素。.我们通过研究证实了EGFRvIII在人胶质瘤U251细胞的促增殖作用,并进一步发现EGFRvIII的促增殖作用是通过促进细胞分裂相关丝裂原蛋白CEP55的表达实现。抑制CEP55的表达可以逆转EGFRvIII在胶质瘤U251细胞的促增殖作用。该研究结果为针对表达EGFRvIII的胶质瘤细胞的靶向治疗选择提供了有力的支持,也为通过抑制CEP55的表达抑制胶质瘤细胞的增殖提供了靶向治疗新方向。.EGFR及EGFRvIII下游的转录因子Egr-1具有电离辐射启动其表达的特点。文献报道的研究结果提示Egr-1具有抑制肿瘤细胞增殖的作用,其表达增高与预后佳正相关。而我们通过检测胶质瘤患者及分析TCGA数据库,发现尽管在胶质瘤细胞Egr-1表达显著低于正常脑组织,但其在细胞接受电离辐射后表达显著增加,而Egr-1表达的增加显著地促进了胶质瘤U251细胞的增殖,通过持续的抑制U251细胞内Egr-1的表达,细胞的增殖显著下降,且Egr-1的促增殖作用是通过直接与增殖调控基因CCND1的启动子序列结合促进其表达实现。由此,通过我们的研究证实了胶质瘤细胞表达EGFRvIII后,细胞通过Egr-1、CCND1、CEP55等分子机制促进了细胞的增殖和放疗抵抗。为下一步逆转胶质瘤的放疗抵抗及抑制胶质瘤细胞的增殖临床研究提供了有力的理论基础。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Overexpression of centrosomal protein 55 regulates the proliferation of glioma cell and mediates proliferation promoted by EGFRvIII in glioblastoma U251 cells
中心体蛋白55的过表达调节胶质瘤细胞的增殖并介导胶质母细胞瘤U251细胞中EGFRvIII促进的增殖
DOI:10.3892/ol.2017.7573
发表时间:2017
期刊:ONCOLOGY LETTERS
影响因子:2.9
作者:HONGFAN ZHU;DIANGANG CHEN;JINLIANG TANG;CHANGLIN HUANG;SHENGQING LV;DONGLIN WANG;GUANGHUI LI
通讯作者:GUANGHUI LI
DOI:--
发表时间:2017
期刊:中华神经外科疾病研究杂志
影响因子:--
作者:朱虹帆;陈典刚;吕胜青;汤金梁;王东林;李光辉
通讯作者:李光辉
Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter.
抑制 EGR1 通过靶向 CCND1 启动子抑制神经胶质瘤增殖
DOI:10.1186/s13046-017-0656-4
发表时间:2017-12-15
期刊:Journal of experimental & clinical cancer research : CR
影响因子:--
作者:Chen DG;Zhu B;Lv SQ;Zhu H;Tang J;Huang C;Li Q;Zhou P;Wang DL;Li GH
通讯作者:Li GH
DOI:DOI: 10.3892/ol.2017.7573
发表时间:2017
期刊:ONCOLOGY LETTERS
影响因子:--
作者:HONGFAN ZHU;DIANGANG CHEN;JINLIANG TANG;CHANGLIN HUANG;SHENGQING LV;DONGLIN WANG;GUANGHUI LI
通讯作者:GUANGHUI LI
DOI:10.1186/s13046-017-0656-4.
发表时间:2017
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:--
作者:Dian-gang Chen;Bo Zhu;Sheng-qing Lv;Hongfan Zhu;Jinliang Tang;Changlin Huang;Qingrui Li;Pu Zhou;Dong-lin Wang;Guang-hui Li
通讯作者:Guang-hui Li
人胶质瘤干细胞自分泌bFGF机制研究及对细胞自我更新的影响
国内基金
海外基金